Amgen owes $406 million for monopolizing cholesterol drug market, US jury says A federal jury in Delaware said on Thursday that biotech company Amgen owes competitor Regeneron more than $406 ...

A Delaware federal trial jury found Thousand Oaks, California-based drug company Amgen Inc. liable Thursday for federal and state antitrust violations amounting to more than $400 million in damages.